Drugs / KCP-330
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01896505 | Jul 2013 → Oct 2016 | sarcoma | Karyopharm Therapeutics Inc | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | KCP-330 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01896505 ↗ |
| Action | Inhibit | “First-in-Class Inhibitor of Nuclear Export” PMID 27458288 ↗ Jul 2016 |